Fla. Admin. Code Ann. R. 64B16-26.301 - Subject Matter for Consultant Pharmacist Course
(1) Jurisprudence.
(a) Laws and regulations, state and federal,
pertaining to institutional pharmacy and health care facilities.
(b) Laws and regulations, state and federal,
pertaining to the safe and controlled storage of alcohol and other related
substances, and relating to fire and health-hazard control.
(c) Laws and regulations, state and federal,
pertaining to collabborative practice agreements.
(2) Policy and Procedures.
(a) Written procedures for outlining the
medication system in effect.
1. Traditional
systems.
2. Unit-dose systems.
a. Centralized.
b. Decentralized.
c. Automated medication
systems.
3. Routine and
emergency use of drugs.
4. After
hours procedure for medication dispensing.
5. Managing drug
shortages.
(b) Record
keeping and reports.
1. Controlled substance
control and record-of-usage.
2.
Alcohol inventory and record-of-usage.
3. Patient drug use control and records.
a. Recalls.
b. Medication use evaluation.
c. Medication errors.
4. Drug charges, methods, accountability, and
reports.
5. Statistical reports of
usage, volume, etc.
6. Written
collaborative practice agreement records.
(c) Regimen review, documentation and
communication.
1. Performing drug regimen
review.
2. Documentation of drug
regiment review.
3. Communication
of findings to appropriate individuals or groups.
(3) Administrative Responsibilities.
(a) Fiscal Control.
1. Perpetual and traditional inventory
systems.
2. Application of EDP
techniques.
(b) Personnel
Management, orientation and training.
(c) Intra-professional relations pertaining
to medication use.
(d)
Inter-professional relations with other members of the institutional health
care team.
1. Pharmacy & Therapeutic
Committee.
a. Rational drug therapy; review of
medication use and prescribing.
b.
Formulary development - evaluation, appraisal, selection, procurement, storage,
distribution, medication safety, criteria for use development and
safety.
c. Automatic stop orders on
potent and dangerous drugs.
d.
Controls on storage and use of investigational drugs.
2. In-service education of nurses and other
health-related personnel.
3.
Infectious Disease Committee.
(e) Facility Review
1. Areas appropraite for evaluation
2. Documentation of evaluations
3. Reporting of
evaluations
(4)
Professional Responsibilities.
(a) Drug
information retrieval and methods of dispersal.
(b) Development of pharmacy
practice.
(c) Development of an IV
Admixture service.
(d) Procedures
to enhance medication safety.
1. Availability
of equipment, technique, etc., to prepare special dosage forms for pediatric
and geriatric patients.
2.
Preparation of sterile dosage forms.
3. Proper writing, transcribing and
initiating and/or transferring patient medication orders; development of
physician's chart order copy system.
4. Safety of patient self-medication and
control of drugs at bedside.
5.
Reporting and trending adverse drug reactions.
6. Screening for potential drug
interactions.
7. Development and
maintenance of up-to-date emergency kits.
(e) Maintain drug quality and safe storage.
1. Procedures for eliminating out-dated
drugs.
2. Requirements for safe and
appropriate storage conditions.
(f) Maintain drug identity.
1. Procedures for labeling, transferring of
bulk medications, etc.
2.
Manufacturing and packaging procedures.
3. Pre-packaging control and
supervision.
(g)
Conducting patient assesments.
(h)
Ordering and evaluating laboratory or clinical tests.
(i) Administration of medicinal
drugs.
(5) The
Institutional Environment.
(a) The
institution's pharmacy function and purpose.
(b) Interdepartmental relationships important
to the institutional pharmacy.
(c)
Understanding of scope of service and in-patient care mission of the
institution.
(d) Special training
with respect to the operation of nursing homes and Extended Care Facilities
(ECF)/pharmacy relationship and special procurement
procedures.
(6) Nuclear
pharmacy.
(a) Procurement.
(b) Compounding.
(c) Quality control procedures.
(d) Dispensing.
(e) Distribution.
(f) Basic radiation protection and
practices.
(g) Consultation and
education to the nuclear medicine community; including patients, pharmacists,
other health professionals, and the general public.
(h) Research and development of new
formulations.
(i) Record
keeping.
(j) Reporting adverse drug
reactions and medication errors.
(k) Screening for potential drug
interaction.
Notes
Rulemaking Authority 465.005, 465.0125 FS. Law Implemented 465.0125 FS.
New 5-19-72, Amended 12-18-74, 10-17-79, Formerly 21S-1.27, 21S-1.027, Amended 7-31-91, Formerly 21S-26.301, 61F10-26.301, 59X-26.301, Amended 5-5-05, 12-20-20.
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.